Eiken Chemical
Eiken Chemical Co., Ltd., commonly referred to as Eiken, is a prominent player in the biotechnology and diagnostics industry, headquartered in Japan. Established in 1950, the company has made significant strides in the development of innovative diagnostic products and laboratory reagents, catering to both domestic and international markets. Eiken's core offerings include a wide range of microbiological testing kits and molecular diagnostics, which are distinguished by their accuracy and reliability. The company has achieved notable milestones, including advancements in rapid testing technologies that enhance patient care and streamline laboratory processes. With a strong market position, Eiken continues to be recognised for its commitment to quality and innovation, making it a trusted name in the healthcare sector.
DitchCarbon Score
How does Eiken Chemical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eiken Chemical's score of 53 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eiken Chemical's reported carbon emissions
In 2023, Eiken Chemical Co., Ltd. reported total carbon emissions of approximately 14,030,388,000 kg CO2e. This figure includes Scope 1 emissions of about 1,333,000 kg CO2e, Scope 2 emissions of approximately 2,669,000 kg CO2e, and a significant contribution from Scope 3 emissions, which totalled around 14,026,246,000 kg CO2e. The combined Scope 1 and 2 emissions amounted to about 4,614,000 kg CO2e. Eiken Chemical has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 56% by FY2030 from a FY2021 baseline. Additionally, the company targets a 25% reduction in absolute Scope 3 emissions by FY2030, using FY2022 as the reference year. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. The company is on track to meet its near-term targets, with progress monitored regularly. Eiken Chemical's commitment to sustainability reflects its dedication to reducing its environmental impact and contributing to climate action within the healthcare equipment and supplies sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 1,934,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 4,884,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eiken Chemical is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
